First and foremost, no cancer is “easy to treat”- cancer is a devastating illness that poses many challenges to patients, doctors and researchers. However, relative to one another, some cancers are more difficult to treat for various reasons. For example, certain cancers, like those of the pancreas and ovaries, are very difficult to detect … More What makes a cancer “hard to treat”?
Have you ever wondered what a typical cancer research lab looks like? If so click the link below and follow researcher Zeynep Kahramanoglu on an interactive digital tour of a lab. You’ll get to see all of the sophisticated equipment used daily to look at cells, measure their properties, and manipulate them to discover new … More Digital Tour of a Cancer Research Lab
For our final Power in Pink Breast Cancer Awareness blog series, we are excited to hear about the world of Clinical Trials and efforts in pushing forward new, more viable therapeutic options. Today we turn our attention to Dr. Philippe Bedard, an oncologist at Princess Margaret Hospital who leads a number of clinical trials. His … More Power in Pink Breast Cancer Awareness Month Blog Series: Pushing for More Effective Therapies
For our second Breast Cancer Awareness Month Blog, we have the pleasure of introducing Dr. Alexandra Easson, a surgical oncologist practicing at Princess Margaret and Mount Sinai Hospitals. She specializes in surgical treatment of Breast Cancer, Colorectal Cancer, and Melanoma. In addition to her extensive clinical work, Dr. Easson is also involved in a number … More Power in Pink: Breast Cancer Awareness Month Blog Series: A Surgeon’s Perspective
One of the many challenges in treating Breast Cancer is unraveling the genetic and molecular changes that cause tumors to form and spread. This is done through basic science research. Information derived from basic science research is necessary to understanding how our cells function normally so that we can identify how diseases such as cancer … More Power in Pink: Breast Cancer Awareness Month Interview with a Basic Science Cancer Researcher